Thank you for Subscribing to Life Science Review Weekly Brief
Patients' need from clinical trials leads to timely and successful trials, and it informs a patient-centric trial design, a marketing strategy, smooth enrollment, and an engaging trial experience.
FREMONT, CA: Sponsors and investigators today are looking to patient-centricity to develop more effective clinical trials. This came across clearly in our recent research, identifying the recruitment support requirements of clinical trial stakeholders. Indeed, in the industry, the top-rated cost-effective patient recruitment strategy is patient-centric design. A patient-centric method is not limited to finding the target patient population or designing a digital mechanism to locate and enroll patients who fit the profile; it is about considering each step's patient perspective. So, here is more about how to create patient recruitment strategies for clinical trials.
Patients seeking new treatment modes want to be informed about the possibilities to take part in clinical studies. However, they also have several concerns about clinical trial participation, which can generate efficient recruitment barriers. Sponsors and researchers must ask this question to uncover and address these several patient concerns.
Patient dropout rates can be increased, and the reasons for dropping out can be many. It is vital to answer this question to understand the factors that could lead to dropout and decide how to mitigate attrition.
The need for a pertinent partnership is about showing sensitivity to the patient's emotional and psychological requirements. It refers to patients' demand to be treated as individuals, not as numbers in a study. They need to see drug makers and researchers demonstrating that participants are valued as people and that their role is also valued. A pertinent issue connected to this is how clinical trials involve a complicated informed consent process. Getting informed consent is a vital first step to ensuring the patient is made fully aware of the study and is empowered to participate in the trial. From the point of consent, the quality of the patient experience throughout the trial is determined by how site staff connects and listens to participants' concerns. Participants are unlikely to trust these staff if they are administering complex processes shrouded in information about a complex study design.